Shares in JXR (ASX: 01951) have climbed over 4% in today's trading session.
At the time of writing, the stock was up 4.19% to HK$2.24, with a turnover of HK$11.33 million.
The upward movement follows the company's release of a positive profit alert.
The firm anticipates it will return to profitability for the first half of the current year, forecasting a net profit of no less than RMB 90 million.
Both adjusted EBITDA and adjusted net profit showed improvement during the period.
This recovery is primarily attributed to the ongoing rebound of the group's U.S. operations, which saw an increase in the number of egg retrieval cycles.
Furthermore, the company's continuous expansion of personalized services has boosted the penetration rate among its VIP clientele.
In China, the wider promotion and adoption of assisted reproductive services have led to an overall rise in new patient visits for infertility treatment.
Concurrently, the company reported that new infertility patient visits for the first half of 2026 totaled 24,169, marking a 9.1% increase compared to the same period in 2025.
The number of egg retrieval cycles reached 14,653, a 6.1% year-on-year growth.
Analyzing performance by region, the overseas business exhibited a robust growth trajectory.
The number of egg retrieval cycles in international markets hit a record high, surging by 42.4% compared to the previous year.
Comments